True Wealth Design’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
SFA
TIA
MFG
MFG
FFA
GI
True Wealth Design's LUCD Position: Q2 2026 in Review
True Wealth Design increased its Lucid Diagnostics (LUCD) stake by 3,883% in Q2 2026, buying an estimated $251 and bringing the position to 239 shares worth $256. The position accounts for ﹤0.01% of the portfolio, ranked #2397.
True Wealth Design first reported a position in LUCD in Q4 2025 and has held it in 3 quarters since. 8 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.
- True Wealth Design held 239 shares of Lucid Diagnostics worth $256 as of Q2 2026.
- True Wealth Design bought 233 Lucid Diagnostics shares in Q2 2026, an estimated $251.
- Lucid Diagnostics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2397 holding.
- True Wealth Design first reported a position in Lucid Diagnostics in Q4 2025 and has held it in 3 quarters since.
- 8 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.
Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.